Subscribe
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
  • Issues
  • 2014
  • November 2014, Vol 4, No 7

November 2014, Vol 4, No 7

Where Did My Data Go?
By Teri U. Guidi, MBA, FAAMA
Practice Management
Read More ›

Influences on Rising Oncology Drug Costs
By Ruth Linn Lander, FACMPE
Read More ›

Taking a Deep Breath Before the Holidays
By Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›

Tattletale or Whistleblower: What’s an Employer to Do?
By Robert D. Orzechowski, MBA, SPHR, SHRM-SCP
Practice Management
Read More ›

Do’s and Don’ts in Physician–Hospital Alignment, Part 3
By Max Reiboldt, CPA
Practice Management
Read More ›

Patient Portals Improve Healthcare, but Are Still Works in Progress
By Chase Doyle
Read More ›

Investing: Where to Put Your Money Now
By Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF; W. Ben, Utley, CFP
Financial Management, Practice Management
Read More ›

Recent Drug Approvals
FDA Approvals, News & Updates
Read More ›

New Clinical Trials Under Way
Clinical Trials Tracker
Read More ›

Beleodaq (Belinostat) Receives FDA Approval for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
By Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›

Page 1 of 2

  • 1
  • 2
View the Latest Issue of OPM
View the Latest Issue
Read Issue

Top Trending Articles

1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
CONNECT
Subscribe
  • About
    • About OPM
    • Mission Statement
    • Editorial Board
    • AOPM
    • Contact
  • Contribute
    • Submit a Manuscript
    • Author Guidelines
  • Connect
    • Join Us on LinkedIn
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© The Lynx Group, LLC. All Rights Reserved. Privacy Policy.